MEF2D Antikörper (pSer444) (Biotin)
Kurzübersicht für MEF2D Antikörper (pSer444) (Biotin) (ABIN710518)
Target
Alle MEF2D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer444
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic phosphopeptide derived from human MEF2D around the phosphorylation site of Ser444
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- MEF2D (Myocyte Enhancer Factor 2D (MEF2D))
-
Andere Bezeichnung
- MEF2D
-
Hintergrund
-
Synonyms: MEF2Dphospho S444, DKFZp686I1536, MADS box transcription factor 2 polypeptide D, Mef2d, MEF2D_HUMAN, myocyte enhancer factor 2D, Myocyte specic enhancer factor 2, polypeptide D, Myocyte specic enhancer factor 2D, myocyte-specic enhancer factor 2D.
Background: MEF2D is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants.
-
Gen-ID
- 4209
Target
-